Terms: = Uterine cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Staging
1176 results:
1. SUCCOR morbidity: complications in minimally invasive versus open radical hysterectomy in early cervical cancer.
Vázquez-Vicente D; Boria F; Castellanos T; Gutierrez M; Chacon E; Manzour N; Minguez JA; Martin-Calvo N; Alcazar JL; Chiva L;
Int J Gynecol Cancer; 2024 Feb; 34(2):203-208. PubMed ID: 38669163
[TBL] [Abstract] [Full Text] [Related]
2. [
Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
[TBL] [Abstract] [Full Text] [Related]
3. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
[TBL] [Abstract] [Full Text] [Related]
4. Anatomical Distribution of Sentinel Lymph Nodes Harvested by Retroperitoneal vNOTES in 34 Consecutive Patients With Early-Stage Endometrial cancer: Analysis of 124 Lymph Nodes.
Huber D; Hurni Y
J Minim Invasive Gynecol; 2024 May; 31(5):438-444. PubMed ID: 38428574
[TBL] [Abstract] [Full Text] [Related]
5. MRI Plain Scan: A Tool in the Management of Cervical cancer during Pregnancy.
Gao F; Qian T; Sun M; Lu Y; Cheng J; Fu L
Curr Med Imaging; 2024; 20():1-8. PubMed ID: 38389369
[TBL] [Abstract] [Full Text] [Related]
6. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of endometrial carcinoma on biopsy as a predictor of final surgical pathology: Are we doing it right? A completed audit cycle and recommendations.
Jassar A; Hemali N; Bhatnagar A
Indian J Pathol Microbiol; 2024; 67(1):68-73. PubMed ID: 38358191
[TBL] [Abstract] [Full Text] [Related]
8. Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study.
Bjørnholt SM; Mogensen O; Bouchelouche K; Sponholtz SE; Parner ET; Hildebrandt MG; Loft A; Neumann G; Bjørn SF; Dahl K; Markauskas A; Frøding LP; Jensen PT
Gynecol Oncol; 2024 Mar; 182():179-187. PubMed ID: 38335900
[TBL] [Abstract] [Full Text] [Related]
9. SUrgical Access and Pattern of Recurrence of Endometrial cancer: The SUPeR Study, a Multicenter Retrospective Observational Study.
Puppo A; Migliaretti G; Landoni F; Uccella S; Camanni M; Ceccaroni M; Delpiano EM; Mantovani G; Roviglione G; Bianchi T; Grassi T; Maggi V; Garzon S; Galli L; Calandra V; Olearo E
J Minim Invasive Gynecol; 2024 Apr; 31(4):321-329. PubMed ID: 38301845
[TBL] [Abstract] [Full Text] [Related]
10. Prediction of recurrence-related factors for patients with early-stage cervical cancer following radical hysterectomy and adjuvant radiotherapy.
Ma GF; Lin GL; Wang ST; Huang YY; Xiao CL; Sun J; Shi TY; Xiang LB
BMC Womens Health; 2024 Jan; 24(1):81. PubMed ID: 38297248
[TBL] [Abstract] [Full Text] [Related]
11. Reviving peritoneal cytology: Exploring its role in endometrial cancer molecular classification.
Villiger AS; Zurbriggen S; Imboden S; Solass W; Christe L; Saner FAM; Gmür A; Rau TT; Mueller MD; Siegenthaler F
Gynecol Oncol; 2024 Mar; 182():148-155. PubMed ID: 38266401
[TBL] [Abstract] [Full Text] [Related]
12. Impact of sentinel lymph node mapping on survival in patients with high-risk endometrial cancer in the early stage: A matched cohort study.
Jaafar E; Gaultier V; Wohrer H; Estevez JP; Gonthier C; Koskas M
Int J Gynaecol Obstet; 2024 May; 165(2):677-684. PubMed ID: 38226675
[TBL] [Abstract] [Full Text] [Related]
13. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
Zhao D; Sun S; Yang Z; Wang P; Qiu H
Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
[TBL] [Abstract] [Full Text] [Related]
14. [Effects of preoperative diagnostic hysteroscopy on peritoneal cytology and prognosis in patients with non-endometrioid carcinoma].
Zhai ZY; Yang L; Li H; Li LW; Shen ZH; Zhang XB; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):903-910. PubMed ID: 38123196
[No Abstract] [Full Text] [Related]
15. Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.
Seino M; Nagase S; Tokunaga H; Yamagami W; Kobayashi Y; Tabata T; Kaneuchi M; Hirashima Y; Niikura H; Yoshino K; Takehara K; Baba T; Katabuchi H; Mikami M
J Gynecol Oncol; 2024 Jan; 35(1):e15. PubMed ID: 38037547
[TBL] [Abstract] [Full Text] [Related]
16. Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY).
Nero C; Bizzarri N; Di Berardino S; Sillano F; Vizzielli G; Cosentino F; Vargiu V; De Iaco P; Perrone AM; Vizza E; Chiofalo B; Uccella S; Ghezzi F; Turco LC; Corrado G; Giannarelli D; Pasciuto T; Zannoni GF; Fagotti A; Scambia G
Eur J Cancer; 2024 Jan; 196():113435. PubMed ID: 38006759
[TBL] [Abstract] [Full Text] [Related]
17. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
[TBL] [Abstract] [Full Text] [Related]
18. Prophylactic anticoagulation after minimally invasive hysterectomy for endometrial cancer: a cost-effectiveness analysis.
Bell S; Orellana T; Garrett A; Smith K; Kim H; Rosiello A; Rush S; Berger J; Lesnock J
Int J Gynecol Cancer; 2023 Dec; 33(12):1875-1881. PubMed ID: 37903564
[TBL] [Abstract] [Full Text] [Related]
19. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
[TBL] [Abstract] [Full Text] [Related]
20. Prevalence of precancerous gynecological lesions and gynecological cancer in patients undergoing vaginal hysterectomy for pelvic organ prolapse.
Suphattanaporn O; Saraluck A; Mononai J; Lekskul N; Chinthakanan O
Ann Med; 2023; 55(2):2273428. PubMed ID: 37883921
[TBL] [Abstract] [Full Text] [Related]
[Next]
